All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Acute graft-versus-host disease (aGvHD) is a major complication following allogeneic hematopoietic stem cell transplant and a leading cause of early non-relapse mortality. It usually develops within the first 100 days after transplantation and typically affects the skin with a maculopapular rash, the gastrointestinal tract with nausea and emesis, and/or the liver causing elevated serum bilirubin concentrations.